SCHEMBL27360252

SCHEMBL27360252

NCCC(O)CCCCCCCc1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 1/20 0.58
MAOA P21397 1/20 0.57
TRPV1 Q8NER1 1/20 0.51
HTR2A P28223 2/20 0.50
S1PR2 O95136 1/20 0.49
S1PR4 O95977 1/20 0.49
S1PR1 P21453 1/20 0.49
S1PR3 Q99500 1/20 0.49
CYP2A6 P11509 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
TAAR1 Q96RJ0 1/20 0.47
LOXL2 Q9Y4K0 1/20 0.47
MAPT P10636 1/20 0.46
RXFP1 Q9HBX9 1/20 0.46
FAAH O00519 1/20 0.46
MAOB P27338 2/20 0.46
CPB2 Q96IY4 1/20 0.45
SIGMAR1 Q99720 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6677440 0.93 MAOA (0.55) TRPA1MAOAHTR2ACYP2A6SMN1; SMN2
SCHEMBL19682101 0.91 TRPA1 (0.67) TRPA1MAOATRPV1S1PR2S1PR4
SCHEMBL11120194 0.87 TRPA1 (0.59) TRPA1MAOATRPV1HTR2AS1PR2
SCHEMBL6680790 0.85 HTR2A (0.54) MAOAHTR2ACYP2A6SMN1; SMN2TAAR1
SCHEMBL5833581 0.82 TRPA1 (0.56) TRPA1MAOATRPV1HTR2ASMN1; SMN2
SCHEMBL1678684 0.82 TRPA1 (0.58) TRPA1TRPV1S1PR2S1PR4S1PR1
SCHEMBL6671960 0.82 TRPA1 (0.58) TRPA1TRPV1HTR2ASIGMAR1
SCHEMBL27177813 0.81 TRPA1 (0.61) TRPA1MAOATRPV1S1PR2S1PR4
SCHEMBL27370822 0.81 TRPA1 (0.61) TRPA1MAOATRPV1S1PR2S1PR4
SCHEMBL15149575 0.81 TRPA1 (0.56) TRPA1TRPV1S1PR2S1PR4S1PR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1056602-C Esters and amides as PLA2 inhibitors FUJISAWA PHARMACEUTICAL CO (JP) 2000-09-20 CN disclosed
CN-1197450-A Esters and amides as phospholipase A2 inhibitors FUJISAWA PHARMACEUTICAL CO (JP) 1998-10-28 CN disclosed